Primary Refractory Double Hit Diffuse Large B cell Lymphoma: Response to Salvage Therapy with Ibrutinib and Rituximab

Authors :: Rammurti T. Kamble
A. Manhas
Gloria Obi
George Carrum
Audrey Scholoff
Source :: Clinical Lymphoma Myeloma and Leukemia. 15:S62-S63
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cancer Research
Double hit
medicine.medical_specialty
business.industry
Salvage therapy
Hematology
medicine.disease
chemistry.chemical_compound
Refractory
chemistry
Ibrutinib
Internal medicine
medicine
Rituximab
business
Diffuse large B-cell lymphoma
medicine.drug

Tools